Woodline Partners’s Alnylam Pharmaceuticals ALNY Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2025 Q2	$203M	Buy	623,115 +466,651	+298%	+$152M	1.07%	6
2025 Q1	$42.2M	Buy	+156,464	New	+$42.2M	0.27%	111
2023 Q1	–	Sell	-95,068	Closed	-$22.6M	–	625
2022 Q4	$22.6M	Buy	+95,068	New	+$22.6M	0.3%	88